Vinge advised Active Biotech on the deal.Active Biotech AB (publ) (Nasdaq Stockholm) carried out a rights issue of approximately SEK 55 million. Active Biotech is a biotechnology…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
